Related content

Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review

By Costello Michael F.   Shrestha Bhushan   Eden John   Johnson Neil P.   Sjoblom Peter  

Human Reproduction, Vol. 22, Iss. 5, 2007-05 ,pp. : 1200-1209

Oxford University Press

Access to resources Recommend Favorite

The impact of oral contraceptives and metformin on anti-Müüllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia

By Panidis Dimitrios   Georgopoulos Neoklis A.   Piouka Athanasia   Katsikis Ilias   Saltamavros Alexandros D.   Decavalas George   Diamanti-Kandarakis Evanthia  

Gynecological Endocrinology, Vol. 27, Iss. 8, 2011-08 ,pp. : 587-592

Informa Healthcare

Access to resources Recommend Favorite

Effect of metformin on the clinical and metabolic assessment of women with polycystic ovary syndrome

By Santana L Ferreira   Sá MF Silva de   Ferriani RA   Moura MD de   Foss MC   Reis RM dos  

Gynecological Endocrinology, Vol. 19, Iss. 2, 2004-08 ,pp. : 88-96

Informa Healthcare

Access to resources Recommend Favorite

Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis

By Hickey M.   Doherty D.A.   Atkinson H.   Sloboda D.M.   Franks S.   Norman R.J.   Hart R.  

Human Reproduction, Vol. 26, Iss. 6, 2011-06 ,pp. : 1469-1477

Oxford University Press

Access to resources Recommend Favorite

Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis

By Nader S.   Diamanti-Kandarakis E.  

Human Reproduction, Vol. 22, Iss. 2, 2007-02 ,pp. : 317-322

Oxford University Press

Access to resources Recommend Favorite